

United States Food and Drug Administration is an agency of the US Department of Health and Human Services.

The US regulator that approved Infilbray for neurological symptoms of type 3 Gaucher disease.
2 min

The US agency granted PRIMA a rare-condition designation and has yet to decide whether to approve it for advanced geographic atrophy.
3 min

The US food and drug regulator remains without a permanent commissioner after the White House withdrew Overton’s nomination.
3 min

The US regulator that launched the program for sharing drug review packages.
3 min
In this storyThe US drug regulator that approved Lembaz for infantile-onset Niemann-Pick disease type C.

In this storyThe US regulator requiring GLP-1 medicine labels to warn of a potential vision-loss risk.

In this storyUS regulator whose March 2026 draft guidance outlines how developers should validate non-animal testing methods.

In this storyThe US drug regulator submitted an interim peptide-access proposal for White House review.

In this storyThe US food regulator proposes extending its food-additive review exemption to ingredients added directly to food.

In this storyThe US medicines regulator retains responsibility for deciding whether personal prescription imports can enter the country.

In this storyThe US drug regulator conducting the mifepristone safety review.

In this storyThe US agency reported to have approved the expandable pediatric heart valve.

In this storyThe US agency that removed a boxed warning from hormone therapy packaging and attributes an estrogen patch shortage to rising demand.

In this storyThe US agency identified in the dispensary’s disclaimer and Blanche’s response.

In this storyThe US regulator is to receive the complete findings in discussions AriBio plans about the drug’s development.

In this storyThe US regulator with which Cognito plans to discuss a possible authorization submission.

In this storyThe US regulator whose certificates and approvals Thailand committed to accept under the earlier framework.

In this storyThe regulator that does not review compounded drugs for safety, effectiveness or quality before sale.

In this storyThe US agency whose drug information was among the sources used to identify potentially actionable variants.

In this storyThe US regulator that expanded approval of Rhythm’s Imcivree treatment.

In this storyThe body required to produce a new action plan under the legislation, according to Calvert’s office.

In this storyThe US drug regulator changing the boxed warnings on menopause treatments.

In this storyThe US regulator that granted Voceryq accelerated approval and requires further trials to verify its clinical benefit.

In this storyThe US regulator that approved Moderna’s new flu vaccine for people aged 50 and older.
